Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-F Hsu

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Human Gene Therapy|February 15, 2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartmentsW F Cheng, C F Hung, K F Hsu, et al.
British Journal of Cancer|July 10, 2015
Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancerK-F Hsu, M-R Shen, Y-F Huang, et al.
Acta Chirurgica Belgica|February 23, 2011
The relationship between acid-suppressing drugs and phytobezoar formation: a retrospective analysis and discussion of phytobezoar formationC Y Fu, C H Chu, T P Liu, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 7, 2010
Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5C-Y Fu, H-H Hsu, J-C Yu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancerK-F Hsu, S-C Huang, A-L Shiau, et al.
Cancer Gene Therapy|May 24, 2008
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapyK-F Hsu, C-L Wu, S-C Huang, et al.
Oncogene|March 15, 2011
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancerS Charoenfuprasert, Y-Y Yang, Y-C Lee, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Human Gene Therapy|February 15, 2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartmentsW F Cheng, C F Hung, K F Hsu, et al.
British Journal of Cancer|July 10, 2015
Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancerK-F Hsu, M-R Shen, Y-F Huang, et al.
Acta Chirurgica Belgica|February 23, 2011
The relationship between acid-suppressing drugs and phytobezoar formation: a retrospective analysis and discussion of phytobezoar formationC Y Fu, C H Chu, T P Liu, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 7, 2010
Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5C-Y Fu, H-H Hsu, J-C Yu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancerK-F Hsu, S-C Huang, A-L Shiau, et al.
Cancer Gene Therapy|May 24, 2008
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapyK-F Hsu, C-L Wu, S-C Huang, et al.
Oncogene|March 15, 2011
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancerS Charoenfuprasert, Y-Y Yang, Y-C Lee, et al.
Pageof 6